[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immunic Inc (IMUX)

Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immunic Inc 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 USA

www.imux.com Employees: 92 P: 332-255-9818

Sector:

Medical

Description:

Immunic Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis and psoriasis. The company's product candidate consists of IMU-838, IMU-935 and IMU-856 which are in clinical stage. Immunic Inc., formerly known as Vital Therapies Inc., is based in San Diego, United States.

Key Statistics

Overview:

Market Capitalization, $K 224,580
Enterprise Value, $K 209,100
Shares Outstanding, K 13,644
Float, K 12,895
% Float 94.51%
Short Interest, K 1,434
Short Float 10.51%
Days to Cover 10.13
Short Volume Ratio 0.52
% of Insider Shareholders 5.49%
% of Institutional Shareholders 51.82%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -97,170 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -34,100 K
EBIT, $ -117,890 K
EBITDA, $ -117,720 K

Growth:

1-Year Return 87.27%
3-Year Return -4.53%
5-Year Return -83.74%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 77.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 08/11/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -4.38
EPS Growth vs. Prev Qtr 25.93%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 04/27/26

IMUX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -157.89%
Return-on-Assets % -107.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.76
Book Value/Share 9.37
Interest Coverage -3.57
60-Month Beta 1.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.